& AHPA Cannabis Committee Chairat
Principal Supplement Advisory Group
Asa Waldstein is founder and principal of the regulatory consulting company Supplement Advisory Group that specializes in marketing risk analysis and practical marketing solutions in the web, social media, and product labels. Asa is a Certified Clinical Herbalist (CCH) with 20 years of experience implementing compliant marketing strategies and cGMP manufacturing processes in the dietary supplement and hemp industries.
Asa has formulated, manufactured, and marketed hundreds of products in a compliant manner and has helped oversee three FDA CFR 111 inspections without any 483s. Asa is Chair of AHPA's (American Herbal Products Association) Cannabis Committee. His Regulatory Education Series platform hosts free events for the community on FDA/FTC enforcement trend analysis, social media marketing principles, and manufacturing efficiency principles.
Chief Science Officerat
Dr. Capano holds a BSN and an MSN from the University of Pennsylvania, as well as a BS in neuroscience from the University of Miami. She earned her doctoral degree at Thomas Jefferson
University in Philadelphia, Pennsylvania, where she graduated Summa Cum Laude and was awarded the Sandra Festa Ryan award for Outstanding Creativity and Innovation.
Dr Capano was the first doctoral candidate of any discipline who focused on cannabinoid science under the guidance of the Lambert Center for the Study of Medicinal Cannabis and Hemp at
Thomas Jefferson University.
Dr. Capano is currently a faculty member of the Lambert Center and a Senior Fellow in the Institute of Emerging Health Professions. Her clinical practice as a family nurse practitioner
includes primary care, with a focus on sexual and reproductive medicine.
Global Lead - Nicotine & Cannabisat
Shane MacGuill conducts research and provides strategic analysis on all aspects of the global tobacco, nicotine and cannabis industries - working with a range of stakeholders to map the potential evolution and intersection of these industries. Working with a range of industry players including international manufacturers and companies in the supply chain, he contributes to discussions on industry trends and strategic development.
A frequent contributor to the mainstream and business media including CNBC, Reuters, the Economist, Bloomberg, the Financial Times, the Sunday Times and the Times of London.
Dr. Allison Justice
Founder and CEOat
The Hemp Mine LLC
Allison Justice graduated Clemson University with a Ph.D. in Plant and Environmental Science. After graduation, Dr. Justice joined the cannabis industry, teaming up with OutCo LLC., a vertically integrated cannabis producer in San Diego, CA. She pioneered industry research focused on controlled agricultural lighting and post-harvest production.
Currently, Dr. Justice is founder and CEO of The Hemp Mine, a South Carolina based vertically integrated hemp company. In addition to farming 30 acres, The Hemp Mine supplies premium hemp young plants bred in house across the US. Additionally, THM conducts contract research for a wide range of vendors providing real results on a large-scale setting. The Hemp Mine produces a wide array of consumer products ranging from smokable flower to topicals to tinctures of different concentrations for both humans and animals. These consumer products are sold in over 1,500 retail stores in the southeast.
Business Development Directorat
Eurofins Food Integrity & Innovation
Vanessa Snyder has a strong passion for health and overall well-being stemming from her studies in nutrition. This led her into the hemp industry, where today she serves as the Business Development Director for Hemp and Botanicals within Eurofins, an industry-leading nutrient, contaminant and microbiology laboratory with 80+ years of experience. In her role, she assists the hemp industry in meeting needs for reliable testing and development of sound quality programs, while continuing to drive support for regulation and standardization within the industry. With over 10 years of experience in food, beverage, feed and dietary supplement industries, Vanessa applies her learned knowledge to aid those working with hemp in maintaining safe, high-quality products to further opportunities throughout the industry.
Vanessa is proud to serve on the Board of Directors for the Hemp Feed Coalition and is an active member of the US Hemp Roundtable, Council for Responsible Nutrition, the American Herbal Products Association, AOAC International and the United Natural Products Alliance. Vanessa holds a Bachelor’s Degree from the University of Wisconsin – Madison in Dietetics and has served as Treasurer for the Wisconsin Institute of Food Technologists and as Secretary for the Wisconsin Lab Association.
Director of Client Strategyat
Kate has 14 years of marketing and communications experience in both established and emerging industries such as Cannabis and CBD. As Director of Client Strategy for Brightfield Group, Kate works with a variety of organizations, including CBD/Cannabis, Pharmaceutical, and mainstream CPG clients helping both product and marketing teams make data-driven decisions. Kate received her M.B.A. from DePaul University's Kellstadt Graduate School of Business, and her B.A. in Anthropology and French from DePaul University.
David is a skilled researcher who has established himself as an expert in the field of cannabis science. David attended UC Irvine where he received his Ph.D. in Organic Chemistry, specializing in Nickel-Catalyzed Cross-Coupling Methodology. After completing his doctoral program, David began his career in cannabis as the Research Principal at CW Analytical, one of California’s first third-party cannabis testing laboratories. During this time, he published seminal work in the field of cannabinoid profiling of complex cannabis-infused matrices with his article “Investigation of Chocolate Matrix Interference on Cannabinoid Analytes”, which was published in the American Chemistry Society’s Journal of Agricultural and Food Chemistry. This work received international recognition, won an Innovation Award from The Cannabis Scientist, and was the focus of an AP News feature on the emerging role of chemistry in the cannabis industry. David serves on the Emerald Conference’s Scientific Advisory Committee, and is a founding member of the Science Advisory Committee of Oakland Hyphae, a community focused collective that aims to develop analytical methods for psilocybin and psilocin testing and to advance the science of entheogens. Currently, David is the Senior Scientist at Via Innovations, a cannabis formulation company focused on designing the next-generation of cannabis products with their fit-for-purpose technology selection and pharmaceutical expertise.
Dr. Miyabe Shields
Chief Science Officerat
Bio coming soon.
Industry Manager - Alcoholic Drinksat
Spiros Malandrakis has been providing pioneering insights on the evolution, branding and innovation within the global alcoholic drinks industry for the past decade. One of the first analysts to highlight the parallels, opportunities and pitfalls for the nascent cannabis market and its intersection with other FMCG industries.
A key author in trade magazines and a frequent contributor to high profile business media such as Bloomberg, the BBC, the Financial Times, Reuters, the WSJ, Spiros is regular keynote speaker in some of the industry’s most sought after conferences, and a firm believer in irreverent, opinionated and independent analysis.
Thompson Hine LLP
Eric has extensive experience advising clients in the cannabis, e-cigarette & vaping industries. He advises clients on FDA and state regulatory compliance and enforcement issues, contractual and transactional matters, and intellectual property issues. Eric was part of a landmark litigation team that helped established the legal framework for the vaping industry as it exists today by successfully arguing against FDA that e-cigarettes are not drugs or medical devices. Eric has won constitutional cases against the State of Indiana on an e-liquid manufacturer licensing scheme and against the State of New York on an emergency rule banning flavored ENDS products. Eric represents clients at all levels of the manufacturing, distribution, and retail levels of the ENDS and cannabis industries and is currently advising a large number of clients on successfully navigating the PACT Act’s requirements.
U.S. Hemp Roundtable
There are few individuals who have been more influential in the development of the U.S. hemp industry that the U.S. Hemp Roundtable’s General Counsel, Jonathan Miller. Upon helping found the Roundtable (and its sister organization, the U.S. Hemp Authority), Jonathan has served as the industry’s leading advocate for hemp and CBD legislation on the ground in Congress and in dozens of state legislatures. A recovering politician (the Democrat was elected twice as Kentucky’s State Treasurer), Jonathan has worked across the aisle with leading hemp champions such as U.S. Senate Minority Leader Mitch McConnell on critical legislation, including the 2014 and 2018 Farm Bills. Now he spends his time working with Congress, the White House, the USDA, FDA and DEA to promote policies that advance the industry. Jonathan serves as Member in Charge of Frost Brown Todd’s Washington, D.C. office, and leads the national law firm’s broad and diverse hemp practice. Jonathan supports pro-Israel organizations and serves as President of the Robert S. Miller Family Foundation for Justice and Equity. He is a poker aficionado who made the final table in a 2012 World Series of Poker tournament.
Dr. Parveen Bhatarah
Head of Regulatory and Complianceat
Dr Parveen Bhatarah, PhD, FRSC, completed her PhD in organic chemistry from Imperial College London and is a Fellow of the Royal Society of Chemistry. She has over 20 years experience within the international pharmaceutical industry & regulatory environment: bulk drug substance and product development; clinical trials; commercial launches; technology transfers; and manufacturing for ANDA and MA submissions. Dr Bhatarah has 12 years’ experience in the Medicinal Cannabis industry, in which she has held various directorship roles covering everything from cultivation to FDA approval of finished medicinal products.